Enabling Big Science in a Small Satellite - The Global L-band Observatory for Water Cycle Studies (GLOWS) Mission

The SMOS and SMAP radiometers have demonstrated the ability to monitor soil moisture and sea surface salinity. It is important to maintain data continuity for these science measurements. The proposed instrument concept (Global L-band active/passive Observatory for Water cycle Studies - GLOWS) will enable low-cost L-band data continuity (that includes both L-band radar and radiometer measurements). The objective of this project is to develop key instrument technology to enable L-band observations using an Earth Venture class satellite. Specifically, a new deployable meta-lens antenna is being developed that will enable a smaller EELV Secondary Payload Adapter (ESPA) Grande-class satellite mission to continue the L-band observations at SMAP and SMOS resolution and accuracy at substantially lower cost, size, and weight. The key to maintaining the scientific value of the observations is the retention of the full 6-meter antenna aperture, while packaging that aperture on a small ESPA Grande satellite platform. The meta-lens antenna is lightweight, has a simplified flat deployed surface geometry, and stows in a compact form factor. This dramatic aperture packaging reduction enables the GLOWS sensor to fit on an Earth Venture class satellite

SWIRP: Compact Submm-Wave and LWIR Polarimeters for Cirrus Ice Properties

Providing critical information on the make-up and distribution of aerosols and clouds, which in turn improve predictions of future climate conditions and help us assess the impacts of aerosols on human health;Addressing key questions about how changing cloud cover and precipitation will affect climate, weather, and Earth's energy balance in the future, advancing understanding of the movement of air and energy in the atmosphere and its impact on weather, precipitation, and severe storms

Improved Calibration through SMAP RFI Change Detection

Anthropogenic Radio-Frequency Interference (RFI) drove both the SMAP (Soil Moisture Active Passive) microwave radiometer hardware and Level 1 science algorithm designs to use new technology and techniques for the first time on a spaceflight project. Care was taken to provide special features allowing the detection and removal of harmful interference in order to meet the error budget. Nonetheless, the project accepted a risk that RFI and its mitigation would exceed the 1.3-K error budget. Thus, RFI will likely remain a challenge afterwards due to its changing and uncertain nature. To address the challenge, we seek to answer the following questions: How does RFI evolve over the SMAP lifetime? What calibration error does the changing RFI environment cause? Can time series information be exploited to reduce these errors and improve calibration for all science products reliant upon SMAP radiometer data? In this talk, we address the first question

Soil Moisture Active Passive (SMAP) Project Algorithm Theoretical Basis Document SMAP L1B Radiometer Data Product: L1B_TB

The purpose of the Soil Moisture Active Passive (SMAP) radiometer calibration algorithm is to convert Level 0 (L0) radiometer digital counts data into calibrated estimates of brightness temperatures referenced to the Earth's surface within the main beam. The algorithm theory in most respects is similar to what has been developed and implemented for decades for other satellite radiometers; however, SMAP includes two key features heretofore absent from most satellite borne radiometers: radio frequency interference (RFI) detection and mitigation, and measurement of the third and fourth Stokes parameters using digital correlation. The purpose of this document is to describe the SMAP radiometer and forward model, explain the SMAP calibration algorithm, including approximations, errors, and biases, provide all necessary equations for implementing the calibration algorithm and detail the RFI detection and mitigation process. Section 2 provides a summary of algorithm objectives and driving requirements. Section 3 is a description of the instrument and Section 4 covers the forward models, upon which the algorithm is based. Section 5 gives the retrieval algorithm and theory. Section 6 describes the orbit simulator, which implements the forward model and is the key for deriving antenna pattern correction coefficients and testing the overall algorithm

A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins.

The Erbb-2 (neu in rat and Her-2 in humans) tyrosine kinase receptor is an oncoantigen (i.e., a tumor- associated molecule directly involved in cancer progression). Because oncoantigens are self-tolerated mole- cules, to trigger a response circumventing tolerance, we generated two plasmids (RHuT and HuRT) coding for chimeric neu-Her-2 extracellular and transmembrane proteins that are expressed on the cell membrane of the transfected cells and recognized by monoclonal antibodies reacting against neu and Her-2. RHuT encodes a protein in which the 410 NH2-terminal residues are from the neu extracellular domain and the remaining residues from Her-2. Almost symmetrically, HuRT encodes for a protein in which the 390 NH2-terminal resi- dues are from Her-2 and the remainder from neu. The ability of RHuT and HuRT to elicit a protective response to neu and Her-2 in wild-type mice and in transgenic mice tolerant to neu and Her-2 proteins was compared with that of plasmids coding for the fully rat or fully human extracellular and transmembrane domains of the Erbb-2 receptor. In most cases, RHuT and HuRT elicited a stronger response, although this chimeric benefit is markedly modulated by the location of the heterologous moiety in the protein coded by the plasmid, the immune tolerance of the responding mouse, and the kind of Erbb-2 orthologue on the targeted tumor

Soil Moisture ActivePassive (SMAP) L-Band Microwave Radiometer Post-Launch Calibration

The SMAP microwave radiometer is a fully-polarimetric L-band radiometer flown on the SMAP satellite in a 6 AM/ 6 PM sun-synchronous orbit at 685 km altitude. Since April, 2015, the radiometer is under calibration and validation to assess the quality of the radiometer L1B data product. Calibration methods including the SMAP L1B TA2TB (from Antenna Temperature (TA) to the Earths surface Brightness Temperature (TB)) algorithm and TA forward models are outlined, and validation approaches to calibration stability/quality are described in this paper including future work. Results show that the current radiometer L1B data satisfies its requirements

Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2

INTRODUCTION: The availability of mice transgenic for the human HER2 gene (huHER2) and prone to the development of HER2-driven mammary carcinogenesis (referred to as FVB-huHER2 mice) prompted us to study active immunopreventive strategies targeting the human HER2 molecule in a tolerant host. METHODS: FVB-huHER2 were vaccinated with either IL-12-adjuvanted human HER2-positive cancer cells or DNA vaccine carrying chimeric human-rat HER2 sequences. Onset and number of mammary tumors were recorded to evaluate vaccine potency. Mice sera were collected and passively transferred to xenograft-bearing mice to assess their antitumor efficacy. RESULTS: Both cell and DNA vaccines significantly delayed tumor onset, leading to about 65% tumor-free mice at 70 weeks, whereas mock-vaccinated FVB-huHER2 controls developed mammary tumors at a median age of 45 weeks. In the DNA vaccinated group, 65% of mice were still tumor-free at about 90 weeks of age. The number of mammary tumors per mouse was also significantly reduced in vaccinated mice. Vaccines broke the immunological tolerance to the huHER2 transgene, inducing both humoral and cytokine responses. The DNA vaccine mainly induced a high and sustained level of anti-huHER2 antibodies, the cell vaccine also elicited interferon (IFN)-gamma production. Sera of DNA-vaccinated mice transferred to xenograft-carrying mice significantly inhibited the growth of human HER2-positive cancer cells. CONCLUSIONS: Anti-huHER2 antibodies elicited in the tolerant host exert antitumoral activity

HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response

Full-length HER2 oncoprotein and splice variant Delta16 are co-expressed in human breast cancer. We studied their interaction in hybrid transgenic mice bearing human full-length HER2 and Delta16 (F1 HER2/Delta16) in comparison to parental HER2 and Delta16 transgenic mice. Mammary carcinomas onset was faster in F1 HER2/Delta16 and Delta16 than in HER2 mice, however tumor growth was slower, and metastatic spread was comparable in all transgenic mice. Full-length HER2 tumors contained few large vessels or vascular lacunae, whereas Delta16 tumors presented a more regular vascularization with numerous endothelium-lined small vessels. Delta16-expressing tumors showed a higher accumulation of i.v. injected doxorubicin than tumors expressing full-length HER2. F1 HER2/Delta16 tumors with high full-length HER2 expression made few large vessels, whereas tumors with low full-length HER2 and high Delta16 contained numerous small vessels and expressed higher levels of VEGF and VEGFR2. Trastuzumab strongly inhibited tumor onset in F1 HER2/Delta16 and Delta16 mice, but not in full-length HER2 mice. Addiction of F1 tumors to Delta16 was also shown by long-term stability of Delta16 levels during serial transplants, in contrast full-length HER2 levels underwent wide fluctuations. In conclusion, full-length HER2 leads to a faster tumor growth and to an irregular vascularization, whereas Delta16 leads to a faster tumor onset, with more regular vessels, which in turn could better transport cytotoxic drugs within the tumor, and to a higher sensitivity to targeted therapeutic agents. F1 HER2/Delta16 mice are a new immunocompetent mouse model, complementary to patient-derived xenografts, for studies of mammary carcinoma onset, prevention and therapy